PTK2 and breast carcinoma: EL suppressed adhesion, motility, and invasion of breast cancer cells by remodeling the actin cytoskeleton, downregulated gene expression of matrix metalloproteinases (MMP-2, −9, and −14), and inhibited FAK signaling [4, 5].